Document Detail


Mean-term calcium heparin treatment in acute transmural anterior myocardial infarction: effects on left ventricular thrombosis and its complications.
MedLine Citation:
PMID:  9534319     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In order to assess the efficacy of 3-month subcutaneous treatment with calcium heparin 12,500 IU twice daily in preventing left ventricular thrombosis and its complications a prospective, controlled, randomized trial was carried out in 204 patients with acute anterior myocardial infarction consecutively enrolled in seven Italian hospitals. Left ventricular thrombosis was diagnosed by means of two-dimensional echocardiography performed at baseline, after 10 and 90 days of treatment. The incidence of thrombosis at the baseline echocardiogram was not significantly different between the treatment and control groups, whereas a significantly lower incidence of thrombi was observed in treated than in control group both on day 10 (3/86, 3.5% and 13/85, 15.3%, respectively; p < 0.05) and day 90 (1/65, 1.5% and 6/57, 10.5%, respectively; p < 0.05). The total incidence of thrombi after 3 months of therapy was significantly lower in calcium heparin-treated patients (19/106, 17.9%) than in controls (31/98, 31.6%; p < 0.05). The incidence of cardiac events (death, reinfarction, angina) in the two groups during the 3-month treatment period was not significantly different. Two embolic events, one cerebral and one pulmonary, occurred in the control group, both after day 10 of treatment.
Authors:
A Iacono
Related Documents :
18220489 - Antiplatelet therapy with clopidogrel and aspirin in vascular diseases: clinical eviden...
19853689 - Design and rationale of the evaluation of m118 in percutaneous coronary intervention (e...
18823219 - Combination antiplatelet agents for secondary prevention of ischemic stroke.
7982419 - Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfar...
21060749 - Clinical benefit of low molecular weight heparin for st-segment elevation myocardial in...
17065179 - Effects of platelet glycoprotein iib/iiia receptor blockers in non-st segment elevation...
10391279 - Transmyocardial laser revascularization: experimental studies in healthy porcine myocar...
8124799 - Major clinical events after coronary stenting. the multicenter registry of acute and el...
19695469 - The case for myocardial ischemia in hypertrophic cardiomyopathy.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Cardiologia (Rome, Italy)     Volume:  42     ISSN:  0393-1978     ISO Abbreviation:  Cardiologia     Publication Date:  1997 Dec 
Date Detail:
Created Date:  1998-05-21     Completed Date:  1998-05-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8506637     Medline TA:  Cardiologia     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  1251-5     Citation Subset:  IM    
Affiliation:
Cattedra di Cardiologia, Istituto Medico-Chirurgico di Cardiologia, Seconda Università degli Studi, Napoli.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / adverse effects,  therapeutic use*
Double-Blind Method
Echocardiography
Female
Heparin / adverse effects,  therapeutic use*
Humans
Male
Middle Aged
Myocardial Infarction / complications,  drug therapy*
Thrombosis / complications,  prevention & control*
Ventricular Dysfunction, Left / complications,  prevention & control*
Chemical
Reg. No./Substance:
0/Anticoagulants; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cor triatriatum associated with degenerative aortic insufficiency in an adult patient.
Next Document:  Female sex is not an independent risk factor in mortality during myocardial revascularization